Abrdn Healthcare Investors (HQH) 10-Year Financial Performance & Capital Metrics

HQH • • Banking & Credit

Financial ServicesAsset ManagementSpecialized & Niche Asset ManagersSector & Commodity Specialists

AboutAbrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.Show more

Net Interest Income $2M +225.6%
Total Revenue $11M +4.6%
Net Income $185M +228.3%
Return on Equity 18.58% +204.7%
Net Interest Margin 0.19% +186.1%
Efficiency Ratio 102.05% -8.5%
ROA 18.56% +206.1%
Equity / Assets 99.87%
Book Value per Share 20.33 +7.9%
Tangible BV/Share 20.33 +7.9%
Debt/Equity -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Well capitalized: 99.9% equity/assets
✓Diversified revenue: 81.3% from non-interest income
✓Trading near 52-week high
✓Trading at only 0.9x book value

✗Weaknesses

✗Weak 3Y average ROE of 2.0%
✗Weak Piotroski F-Score: 2/9
✗Weak NIM of 0.2%
✗High cost structure: 102.0% efficiency ratio

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y17.52%

5Y7.22%

3Y18.45%

TTM-

Profit (Net Income) CAGR

10Y-1.81%

5Y-

3Y6.02%

TTM717.82%

EPS CAGR

10Y-5.42%

5Y-

3Y0.57%

TTM778.57%

ROCE

10Y Avg-0.38%

5Y Avg-0.25%

3Y Avg-0.17%

Latest-0.02%

Peer Comparison

Sector & Commodity Specialists

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NHICNewHold Investment Corp III	216.79M	10.37	515.92			1.6%
PLTSPlatinum Analytics Cayman Limited Class A Ordinary Shares	196.1M	17.50	245.10	280.21%	35.16%
SOLSSolstice Advanced Materials Inc.	9.6B	60.51	22.75	3.32%	11.19%	13.59%	5.68%	0.13
HQLTekla Life Sciences Investors	491.34M	16.60	21.01	23.61%	56.75%	-13.43%
SWKHSWK Holdings Corporation	211.44M	17.48	16.19	19.14%	29.98%	8.94%	10.84%	0.13
BURBurford Capital Limited	2.15B	9.83	14.89	-56.23%	31.02%	2.7%	10.04%	0.55
ASAASA Gold and Precious Metals Limited	1.2B	63.48	10.48	9.47%	96.94%	39.78%
STKESol Strategies Inc. Common Shares	64.53M	2.30	7.19			-4.25%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Interest Income+	0	0	0	0	0	0	0	112.31K	620.01K	2.02M
NII Growth %	-	-	-	-	-	-	-	-	4.52%	2.26%
Net Interest Margin %	-	-	-	-	-	-	-	-	-	-
Interest Income	0	0	0	0	0	0	0	112.31K	620.01K	2.02M
Interest Expense	0	0	0	0	0	0	0	0	0	0
Loan Loss Provision	0	0	0	0	0	0	0	0	0	0
Non-Interest Income+	4.33M	4.8M	5.62M	6.78M	7.6M	8.93M	6.48M	8.16M	9.67M	8.75M
Non-Interest Income %	-	-	-	-	-	-	-	-	-	-
Total Revenue+	4.33M	4.8M	5.62M	6.78M	7.6M	8.93M	6.48M	8.27M	10.29M	10.77M
Revenue Growth %	1.02%	0.11%	0.17%	0.21%	0.12%	0.18%	-0.27%	0.28%	0.24%	0.05%
Non-Interest Expense	12.18M	11.08M	10.78M	10.9M	10.47M	10.9M	12.71M	11.94M	11.48M	10.99M
Efficiency Ratio	-	-	-	-	-	-	-	-	-	-
Operating Income+	-7.85M	-6.28M	-5.16M	-4.12M	-2.87M	-1.97M	-6.23M	-3.67M	-1.19M	-220.27K
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-0.1%	0.2%	0.18%	0.2%	0.3%	0.31%	-2.16%	0.41%	0.68%	0.81%
Pretax Income+	96.17M	-56.02M	121.28M	69.2M	-145.29M	241.2M	155.18M	-194.23M	56.33M	184.95M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	96.17M	-56.02M	121.28M	69.2M	-145.29M	241.2M	155.18M	-194.23M	56.33M	184.95M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0.57%	-1.58%	3.17%	-0.43%	-3.1%	2.66%	-0.36%	-2.25%	1.29%	2.28%
Net Income (Continuing)	96.17M	-56.02M	121.28M	69.2M	-145.29M	241.2M	155.18M	-194.23M	56.33M	184.95M
EPS (Diluted)+	2.58	-1.44	2.98	1.64	-3.39	5.50	3.49	-4.10	1.14	3.55
EPS Growth %	-0.58%	-1.56%	3.07%	-0.45%	-3.07%	2.62%	-0.37%	-2.17%	1.28%	2.11%
EPS (Basic)	2.58	-1.44	2.98	1.64	-3.39	5.50	3.49	-4.10	1.14	3.55
Diluted Shares Outstanding	37.3M	39M	40.65M	42.22M	42.83M	43.87M	45.43M	47.34M	49.44M	52.13M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash & Short Term Investments+	209.55K	883	1000K	927	1000K	0	935	792	214	56
Cash & Due from Banks	209.55K	883	6.46M	927	1.65M	0	935	792	214	56
Short Term Investments	0	0	0	0	0	0	0	0	0	0
Total Investments+	1.06B	907.01M	1B	1.02B	816.92M	996.8M	1.07B	804.79M	824.65M	1.04B
Investments Growth %	0.05%	-0.14%	0.1%	0.02%	-0.2%	0.22%	0.08%	-0.25%	0.02%	0.26%
Long-Term Investments	1.06B	907.01M	1B	1.02B	816.92M	996.8M	1.07B	804.79M	824.65M	1.04B
Accounts Receivables	1000K	1000K	184.62K	459.02K	1000K	1000K	1000K	1000K	1000K	495.64K
Goodwill & Intangibles+	-	-	-	-	-	-	-	-	-	-
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0
PP&E (Net)	0	0	0	0	0	0	0	0	0	0
Other Assets	380.02K	44.29M	34.15M	49.03M	33.48M	52.18M	88.44M	78.78M	68.2M	21.56M
Total Current Assets	61.23M	58.27M	33.15M	18.64M	27.38M	6.84M	12.4M	42.71M	39.64M	603.88K
Total Non-Current Assets	1.06B	951.3M	1.03B	1.07B	850.4M	1.05B	1.16B	883.57M	892.85M	1.06B
Total Assets+	1.12B	1.01B	1.07B	1.09B	877.78M	1.06B	1.17B	926.28M	932.49M	1.06B
Asset Growth %	0.06%	-0.1%	0.06%	0.02%	-0.19%	0.2%	0.11%	-0.21%	0.01%	0.14%
Return on Assets (ROA)	0.09%	-0.05%	0.12%	0.06%	-0.15%	0.25%	0.14%	-0.19%	0.06%	0.19%
Accounts Payable	12.23M	33.73M	8.62M	2.61M	5.97M	0	0	0	0	0
Total Debt+	0	0	0	0	0	0	11.33M	8.5M	0	0
Net Debt	-209.55K	-883	-6.46M	-927	-1.65M	0	11.33M	8.49M	-214	-56
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Short-Term Debt	0	0	0	0	0	0	11.33M	8.5M	0	0
Other Liabilities	0	0	0	0	0	31.4K	15.63M	0	1.15M	0
Total Current Liabilities	13.7M	34.79M	9.76M	3.76M	6.93M	1.09M	15.63M	9.71M	1.15M	1.4M
Total Non-Current Liabilities	0	0	0	0	0	31.4K	15.63M	0	1.15M	0
Total Liabilities	13.7M	34.79M	9.76M	3.76M	6.93M	1.12M	15.63M	9.71M	1.15M	1.4M
Total Equity+	1.1B	974.78M	1.06B	1.08B	870.85M	1.05B	1.16B	916.56M	931.34M	1.06B
Equity Growth %	0.05%	-0.12%	0.09%	0.02%	-0.19%	0.21%	0.1%	-0.21%	0.02%	0.14%
Equity / Assets (Capital Ratio)	-	-	-	-	-	-	-	-	-	-
Return on Equity (ROE)	0.09%	-0.05%	0.12%	0.06%	-0.15%	0.25%	0.14%	-0.19%	0.06%	0.19%
Book Value per Share	29.61	24.99	26.02	25.62	20.33	24.04	25.47	19.36	18.84	20.33
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-
Common Stock	670.99M	712.51M	749.59M	784.49M	796.14M	438.72K	454.25K	473.44K	494.42K	521.3K
Additional Paid-in Capital	0	0	0	0	0	814.74M	853.35M	891.27M	924.88M	941.13M
Retained Earnings	433.37M	262.28M	308.05M	297.26M	74.71M	239.52M	303.1M	24.82M	5.97M	117.95M
Accumulated OCI	0	0	0	0	0	0	0	0	0	0
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Preferred Stock	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	0	0	0	0	0	0	0	0	0	0
Operating CF Growth %	1%	-	-	-	-	-	-	-	-	-
Net Income	96.17M	-56.02M	121.28M	69.2M	-145.29M	241.2M	155.18M	-194.23M	56.33M	184.95M
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-96.17M	56.02M	-121.28M	-69.2M	145.29M	-241.2M	-155.18M	194.23M	-56.33M	-184.95M
Working Capital Changes	0	0	0	0	0	0	0	0	0	0
Cash from Investing+	0	0	0	0	0	0	0	0	0	0
Purchase of Investments	0	0	0	0	0	0	0	0	0	0
Sale/Maturity of Investments	0	0	0	0	0	0	0	0	0	0
Net Investment Activity	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0
Other Investing	0	0	0	0	0	0	0	0	0	0
Cash from Financing+	0	0	0	0	0	0	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0
Stock Issued	0	0	0	0	0	0	0	0	0	0
Net Stock Activity	-	-	-	-	-	-	-	-	-	-
Debt Issuance (Net)	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	0	0	0	0
Net Change in Cash+	-1.12K	0	0	0	0	0	0	0	0	0
Exchange Rate Effect	0	0	0	0	0	0	0	0	0	0
Cash at Beginning	1.12K	0	0	0	0	0	0	0	0	0
Cash at End	0	0	0	0	0	0	0	0	0	0
Interest Paid	0	0	0	0	0	0	0	0	0	0
Income Taxes Paid	0	0	0	0	0	0	0	0	0	0
Free Cash Flow+	0	0	0	0	0	0	0	0	0	0
FCF Growth %	1%	-	-	-	-	-	-	-	-	-

Banking Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	8.91%	-5.39%	11.93%	6.47%	-14.88%	25.05%	14.03%	-18.73%	6.1%	18.58%
Return on Assets (ROA)	8.85%	-5.27%	11.68%	6.43%	-14.8%	24.95%	13.93%	-18.51%	6.06%	18.56%
Net Interest Margin	0%	0%	0%	0%	0%	0%	0%	0.01%	0.07%	0.19%
Efficiency Ratio	281.25%	230.86%	191.91%	160.74%	137.78%	122.07%	196.14%	144.38%	111.52%	102.05%
Equity / Assets	98.77%	96.55%	99.09%	99.65%	99.21%	99.89%	98.67%	98.95%	99.88%	99.87%
Book Value / Share	29.61	24.99	26.02	25.62	20.33	24.04	25.47	19.36	18.84	20.33
NII Growth	-	-	-	-	-	-	-	-	452.04%	225.57%

Frequently Asked Questions

Valuation & Price

Abrdn Healthcare Investors (HQH) has a price-to-earnings (P/E) ratio of 5.4x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Abrdn Healthcare Investors (HQH) grew revenue by 4.6% over the past year. Growth has been modest.

Yes, Abrdn Healthcare Investors (HQH) is profitable, generating $241.3M in net income for fiscal year 2024 (1717.4% net margin).

Dividend & Returns

Abrdn Healthcare Investors (HQH) has a return on equity (ROE) of 18.6%. This is reasonable for most industries.

Industry Metrics

Abrdn Healthcare Investors (HQH) has a net interest margin (NIM) of 0.2%. NIM has been under pressure due to interest rate environment.

Abrdn Healthcare Investors (HQH) has an efficiency ratio of 102.0%. This is higher than peers, suggesting room for cost optimization.

← Back to Screener

US Stock Screener

...